First Rounders

First Rounders

By Nature Biotechnology
Download on the App Store

First Rounders episodes

  • First Rounder: Kari Stefansson
    Kari Stefansson's conversation with Nature Biotechnology covers the founding of deCODE, his love for literature (and his favorite poet), plus his encounter with the tortured chess grandmaster Bobby Fischer.

    Hosted on Acast. See acast.com/privacy for more information.

    56 min
  • First Rounder: Kari Stefansson
    Kari Stefansson's conversation with Nature Biotechnology covers the founding of deCODE, his love for literature (and his favorite poet), plus his encounter with the tortured chess grandmaster Bobby Fischer. For information regarding your data privacy, visit acast.com/privacy
    56 min
  • First Rounder: Kari Stefansson
    Kari Stefansson talks about the founding of deCODE, his love for literature (and his favorite poet), plus his encounter with the tortured chess grandmaster Bobby Fischer.
    56 min
  • First Rounder: Carl Feldbaum
    Carl Feldbaum was the founding president of the Biotechnology Industry Organization (BIO), and he is the current chairman of the Life Sciences Foundation. His podcast conversation with Nature Biotechnology touches on his assistance in prosecuting Watergate, his visit to Saddam Hussein's palace and how he built BIO from the ground up.

    Hosted on Acast. See acast.com/privacy for more information.

    1 hr 8 min
  • First Rounder: Carl Feldbaum
    Carl Feldbaum was the founding president of the Biotechnology Industry Organization (BIO), and he is the current chairman of the Life Sciences Foundation. His podcast conversation with Nature Biotechnology touches on his assistance in prosecuting Watergate, his visit to Saddam Hussein's palace and how he built BIO from the ground up. For information regarding your data privacy, visit acast.com/privacy
    1 hr 8 min
  • First Rounder: Carl Feldbaum
    Carl Feldbaum was the founding president of the Biotechnology Industry Organization (BIO), and he is the current chairman of the Life Sciences Foundation. His podcast conversation with Nature Biotechnology touches on his assistance in prosecuting Watergate, his visit to Saddam Hussein's palace and how he built BIO from the ground up.
    1 hr 8 min
  • First Rounder: Daphne Zohar
    Daphne Zohar is the founder, CEO and managing partner at PureTech, a venture creation company with a new approach to building biotechs, and she sits on the board of several life science firms. Her conversation with Nature Biotechnology covers starting her first company (in high school), the usefulness of Bioentrepreneur courses, and women in venture capital. (Updated February 6, 2015).

    Hosted on Acast. See acast.com/privacy for more information.

    49 min
  • First Rounder: Daphne Zohar
    Daphne Zohar is the founder, CEO and managing partner at PureTech, a venture creation company with a new approach to building biotechs, and she sits on the board of several life science firms. Her conversation with Nature Biotechnology covers starting her first company (in high school), the usefulness of Bioentrepreneur courses, and women in venture capital. (Updated February 6, 2015) For information regarding your data privacy, visit acast.com/privacy
    49 min
  • First Rounder: Daphne Zohar
    Daphne Zohar is the founder, CEO and managing partner at PureTech, a venture creation company with a new approach to building biotechs, and she sits on the board of several life science firms. Her podcast conversation with Nature Biotechnology covers starting her first company (in high school), the usefulness of Bioentrepreneur courses, and women in venture capital.
    49 min
  • First Rounder: Mary Tanner
    Mary Tanner details the Amgen-Immunex buyout, defines 'wildcatting' and suggests the years in which children most need a parent around the house.

    Hosted on Acast. See acast.com/privacy for more information.

    57 min

About First Rounders

From the publisher's feed

Nature Biotechnology's First Rounders podcast is a series of conversations with founders, financers and developers from biotech's past, present and future.

Hosted on Acast. See